Lens element
    1.
    发明授权

    公开(公告)号:US10948744B1

    公开(公告)日:2021-03-16

    申请号:US17134606

    申请日:2020-12-28

    Abstract: A lens element worn in front of an eye of a person includes a refraction area having a first refractive power based on a prescription for correcting an abnormal refraction of the eye of the person and a second refractive power different from the first refractive power and a plurality of at least three optical elements, at least one optical element having an optical function of not focusing an image on the retina of the eye so as to slow down the progression of the abnormal refraction of the eye.

    Progressive multifocal ophthalmic lens designed to inhibit progressive myopia of the wearer

    公开(公告)号:US09791718B2

    公开(公告)日:2017-10-17

    申请号:US14418715

    申请日:2013-07-29

    CPC classification number: G02C7/066 G02C7/027 G02C7/028 G02C7/065 G02C2202/24

    Abstract: Progressive multifocal ophthalmic lens having a power addition (Add) and an astigmatism prescription, and having a far vision point CM, a near vision point NV, and an intermediate vision point IV positioned between CM and NV. The resulting astigmatism in the far and near vision zones is smaller than or equal to the resulting astigmatism in the intermediate vision zone, wherein the resulting astigmatism is the difference between the prescribed astigmatism and the astigmatism generated by the working lens under usual wear conditions. The lens provides good optical quality images in the far and near vision zones, and the resulting astigmatism in the intermediate vision zone encourages the wearer to use the far and near vision zones rather than the intermediate vision zone, thus reducing the risk of increasing the degree of myopia of the wearer in the long term.

    Lens element
    5.
    发明授权

    公开(公告)号:US11442290B2

    公开(公告)日:2022-09-13

    申请号:US17534864

    申请日:2021-11-24

    Abstract: A lens element worn in front of an eye of a person includes a refraction area having a first refractive power based on a prescription for correcting an abnormal refraction of the eye of the person and a second refractive power different from the first refractive power and a plurality of at least three optical elements, at least one optical element having an optical function of not focusing an image on the retina of the eye so as to slow down the progression of the abnormal refraction of the eye.

    PROGRESSIVE OPHTHALMIC LENS
    7.
    发明申请
    PROGRESSIVE OPHTHALMIC LENS 有权
    渐进式眼镜

    公开(公告)号:US20150168743A1

    公开(公告)日:2015-06-18

    申请号:US14418715

    申请日:2013-07-29

    CPC classification number: G02C7/066 G02C7/027 G02C7/028 G02C7/065 G02C2202/24

    Abstract: The invention relates to a progressive multifocal ophthalmic lens comprising a power addition prescription Add and a complex surface, the complex surface comprising having far and near vision zone with resulting astigmatism smaller than Add/3 and an intermediate vision zone with resulting astigmatism greater than Add/3.

    Abstract translation: 本发明涉及包括功率增加处方Add和复杂表面的渐进多焦点眼科镜片,所述复合表面包括具有远近视觉区域且具有小于Add / 3的散光和具有大于Add / 3的中间视区, 3。

    Method and apparatus for evaluating efficacy of ophthalmic lens in controlling sightedness impairment

    公开(公告)号:US12135468B2

    公开(公告)日:2024-11-05

    申请号:US17312148

    申请日:2019-12-11

    Abstract: A method to select or to conceive/design lenses is provided. The method may be applied to lenses having effect of myopia control, visual fatigue relief, etc. In one aspect, a predictive model that ranks myopia control solutions according to visual, behavioral, and biometric parameter is provided. The predictive model may be built based on the myopic eye characteristics, the behavior of the wearers, and the defocus induced by the myopia control solution. In another aspect, a method, a computer-readable medium, and an apparatus for evaluating the efficacy of an ophthalmic lens in controlling at least one sightedness impairment (e.g., myopia) of at least one wearer of the ophthalmic lens are provided. The apparatus may determine, based on a predetermined relationship model, the efficacy of the ophthalmic lens for at least one wearer from representative data corresponding to the at least one wearer.

Patent Agency Ranking